☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Advertisement
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
All Posts by Date
Insights+ Key Biosimilars Events of January 2023
February 1, 2023
Biosynex Entered into a Definitive Merger Agreement to Acquire Chembio Diagnostics for ~$17.2M
February 1, 2023
Jazz Pharmaceuticals’ Epidyolex (cannabidiol) Receives NICE Recommendation for the Reimbursement to Treat Seizures in England
February 1, 2023
Roche Receives the EC's Approval for Label Expansion Approval of Hemlibra (emicizumab) for Moderate Haemophilia A
February 1, 2023
Amgen Launches First Humira (adalimumab) Biosimilar Amjevita in the US
February 1, 2023
Context Therapeutics’ Clinical Partner Stemline Therapeutics Receives the US FDA’s Approval of Orserdu (elacestrant) for ER+, HER2...
February 1, 2023
Load more...
Back to Home
Stay Connected
LinkedIn
Twitter
Facebook
instagram
Youtube
Join the PharmaShots family of 12000+ subscribers
Newsletter
Subscribe Now
I accept the
Terms and Conditions